Auxly Cannabis Group (CVE:XLY) Price Target Cut to C$0.40

Auxly Cannabis Group (CVE:XLYGet Rating) had its target price reduced by equities research analysts at Raymond James from C$0.65 to C$0.40 in a note issued to investors on Friday, BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. Raymond James’ price objective would suggest a potential upside of 2.56% from the stock’s previous close.

Separately, ATB Capital set a C$0.40 price target on shares of Auxly Cannabis Group and gave the company an “outperform” rating in a research report on Thursday, April 7th.

XLY stock opened at C$0.39 on Friday. The firm has a market cap of C$289.90 million and a PE ratio of -2.10. The company has a debt-to-equity ratio of 56.23, a quick ratio of 0.63 and a current ratio of 1.82. The firm’s 50 day moving average price is C$0.39 and its 200-day moving average price is C$0.39. Auxly Cannabis Group has a one year low of C$0.12 and a one year high of C$0.51.

Auxly Cannabis Group Company Profile (Get Rating)

Auxly Cannabis Group Inc operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names.

Further Reading

Receive News & Ratings for Auxly Cannabis Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auxly Cannabis Group and related companies with MarketBeat.com's FREE daily email newsletter.